Literature DB >> 11773111

Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae.

César García-Rey1, Lorenzo Aguilar, Fernando Baquero, Julio Casal, Rafael Dal-Ré.   

Abstract

A geographical analysis of how commonly prescribed oral antibiotics are quantitatively and qualitatively responsible for the different local rates of erythromycin and penicillin resistance in Streptococcus pneumoniae in Spain is presented. From 1998 to 1999 a multicenter surveillance study yielded 1,684 consecutive S. pneumoniae isolates from community-acquired respiratory infections. Data on antibiotic sales in the retail market for the same period were gathered, and the corresponding defined doses per 1,000 inhabitants per day were calculated. Macrolides and beta-lactams were considered separately. Macrolides were subdivided into thrice-, twice-, and once-a-day macrolides, and beta-lactams were split into aminopenicillins and cephalosporins. Univariate Spearman nonparametric coefficients (R) were calculated, and variables proving to be significantly associated (P < 0.1) were entered into several multiple lineal regression models. Ample variation in both resistance rates and antibiotic consumption was seen. Multivariate analyses showed that integrated consumption of both macrolides and beta-lactams accounted well for erythromycin (R(2) = 0.722; P = 0.002) and penicillin (R(2) = 0.706; P = 0.002) resistance. Macrolides were more important drivers for local differences in both erythromycin and penicillin resistance than beta-lactams were. Consumption of once-a-day macrolides was key for local erythromycin resistance variations. Cephalosporins were slightly more important penicillin resistance drivers than aminopenicillins were.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773111      PMCID: PMC120130          DOI: 10.1128/JCM.40.1.159-164.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics.

Authors:  F W Goldstein
Journal:  J Antimicrob Chemother       Date:  1999-08       Impact factor: 5.790

2.  Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Marco; E Bouza; J García-de-Lomas; L Aguilar
Journal:  J Antimicrob Chemother       Date:  2000-10       Impact factor: 5.790

3.  Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage.

Authors:  J Raymond; I Le Thomas; F Moulin; A Commeau; D Gendrel; P Berche
Journal:  J Infect Dis       Date:  2000-05-22       Impact factor: 5.226

4.  Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).

Authors:  J J Granizo; L Aguilar; J Casal; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-12       Impact factor: 5.790

5.  The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.

Authors:  D Felmingham; R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2000-02       Impact factor: 5.790

6.  Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics.

Authors:  E Melander; K Ekdahl; G Jönsson; S Mölstad
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

7.  Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).

Authors:  J J Granizo; L Aguilar; J Casal; C García-Rey; R Dal-Ré; F Baquero
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

8.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae.

Authors:  R Muñoz; T J Coffey; M Daniels; C G Dowson; G Laible; J Casal; R Hakenbeck; M Jacobs; J M Musser; B G Spratt
Journal:  J Infect Dis       Date:  1991-08       Impact factor: 5.226

10.  The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia.

Authors:  N Stingemore; G R Francis; M Toohey; D B McGechie
Journal:  Med J Aust       Date:  1989-06-05       Impact factor: 7.738

View more
  34 in total

1.  The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy.

Authors:  D Boccia; S Spila Alegiani; A Pantosti; M L Moro; G Traversa
Journal:  Eur J Clin Pharmacol       Date:  2004-03-10       Impact factor: 2.953

2.  Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.

Authors:  Asunción Fenoll; Lorenzo Aguilar; María-José Giménez; María-Dolores Vicioso; Olga Robledo; Juan-José Granizo; Pilar Coronel
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.

Authors:  Miika Bergman; Solja Huikko; Pentti Huovinen; Pirkko Paakkari; Helena Seppälä
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

4.  Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Nelson L Jumbe; Arnold Louie; Michael H Miller; Weiguo Liu; Mark R Deziel; Vincent H Tam; Reetu Bachhawat; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

Authors:  Ruth Link-Gelles; Ann Thomas; Ruth Lynfield; Sue Petit; William Schaffner; Lee Harrison; Monica M Farley; Deborah Aragon; Megin Nicols; Pam Daily Kirley; Shelley Zansky; James Jorgensen; Billie Anne Juni; Delois Jackson; Matthew R Moore; Marc Lipsitch
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

6.  Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006.

Authors:  Elizabeth M Brown; David N Fisman; Steven J Drews; Sharon Dolman; Prasad Rawte; Shirley Brown; Frances Jamieson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices.

Authors:  Chris C Butler; Frank Dunstan; Margaret Heginbothom; Brendan Mason; Zoë Roberts; Sharon Hillier; Robin Howe; Stephen Palmer; Anthony Howard
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

8.  The relationship among antibiotic consumption, socioeconomic factors and climatic conditions.

Authors:  Fawziah Marra; Sunny Mak; Mei Chong; David M Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

9.  Antimicrobial resistance gene distribution: a socioeconomic and sociocultural perspective.

Authors:  Kayode K Ojo; Amy R Sapkota; Tokunbo B Ojo; Paul S Pottinger
Journal:  GMS Krankenhhyg Interdiszip       Date:  2008-09-03

10.  Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain.

Authors:  Lars Bjerrum; Albert Boada; Josep M Cots; Carlos Llor; Dolors Forés Garcia; Bente Gahrn-Hansen; Anders Munck
Journal:  Eur J Clin Pharmacol       Date:  2003-12-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.